Mount Sinai Medical Center 1st in Tri-State Area to Discharge Patient without Human Heart
SynCardia Total Artificial Heart Patient Daquain Jenkins Rejected His First Heart Transplant, Waits for Second Donor Heart at Home Using the Freedom® Portable Driver
TUCSON, Ariz. – Nov. 8, 2012 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that The Mount Sinai Medical Center in New York City, has become the first hospital in the tri-state area to discharge a patient implanted with the SynCardia temporary Total Artificial Heart. On Oct. 25, Daquain Jenkins left the hospital to wait for a matching donor heart at home using the Freedom® portable driver to power his Total Artificial Heart.
"We believed that the SynCardia Total Artificial Heart was the only hope of saving Daquain's life, and as part of Mount Sinai's commitment to providing the best care for our patients, we made sure he got it," said Dr. Anelechi Anyanwu, Associate Professor of Cardiothoracic Surgery. "The portable driver will help him maintain his quality of life as he will be able to go home, enjoy being with his kids, and resume his activities of daily living."
Mr. Jenkins, 28, says he is grateful the Freedom portable driver will give him the opportunity to walk his kids to the bus stop; a simple task he was unable to do when his first heart transplant failed.
“Without this device, I wouldn’t be here,” said Mr. Jenkins. “Now, I take everything life brings me with a smile.”
At age 25, Mr. Jenkins was diagnosed with congestive heart failure when he went to the doctor with symptoms of pneumonia. His father had died of heart failure at age 28. Mr. Jenkins began medical therapy, which worked for a year before he started experiencing symptoms again. He was implanted with a pacemaker and a defibrillator at a local hospital, but his condition continued to deteriorate.
When Mr. Jenkins’ local cardiologist recommended he come to Mount Sinai for treatment, Dr. Ajith Nair, Assistant Professor of Medicine (Cardiology), evaluated him and recommended he undergo heart transplantation. In April 2011, he received a heart transplant at Mount Sinai, but after a year, his body rejected the donor heart.
Both sides of Mr. Jenkins’ donor heart were failing rapidly. To save his life, a team was assembled and certified in two days, the SynCardia Total Artificial Heart was flown in from Arizona and on Aug. 17, doctors performed Mount Sinai’s first implant during an eight-hour surgery, proctored by world-renowned heart surgeon Dr. Jack Copeland.
Weighing 13.5 pounds (~6 kg), the Freedom portable driver is the world’s first wearable power supply for the SynCardia Total Artificial Heart. The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
Read press release from Mount Sinai Medical Center
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463